UPDATE - Canaccord Genuity Initiates Coverage on Angie's List (ANGI) with a Buy; Strong Margins in Mature Markets
Tweet
Share
E-mailGet Alerts ANGI Hot Sheet
Price: $4.92 +7.89%
Rating Summary:
12 Buy, 21 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 21 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity initiates coverage on Angie's List (Nasdaq: ANGI) with a Buy. PT $20.
Analyst, Michael Graham, said, "In ANGI’s most mature markets, we believe EBITDA margins are as high as 40-50%, with scope to move higher. Over time, we believe more recent market launches will approach these levels, leading to a business that is more profitable than most investors currently appreciate."
"We project losses through 2013, which could lead to stock volatility. The competitive landscape could intensify with well-funded competitors like Yelp (Nasdaq; YELP) and ServiceMagic. Angie’s must employ a fairly large local sales force, which could impede evolution of operating leverage."
To see more ratings on ANGI, Click Here
Analyst, Michael Graham, said, "In ANGI’s most mature markets, we believe EBITDA margins are as high as 40-50%, with scope to move higher. Over time, we believe more recent market launches will approach these levels, leading to a business that is more profitable than most investors currently appreciate."
"We project losses through 2013, which could lead to stock volatility. The competitive landscape could intensify with well-funded competitors like Yelp (Nasdaq; YELP) and ServiceMagic. Angie’s must employ a fairly large local sales force, which could impede evolution of operating leverage."
To see more ratings on ANGI, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- Keefe, Bruyette & Woods Resumes Bank of Montreal (BMO:CN) (BMO) at Outperform
- TD Cowen Assumes Atara Biotherapeutics (ATRA) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
